Sequana Medical NV
XBRU:SEQUA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Concert Pharmaceuticals Inc
F:73C
|
US |
|
HLV Ltd
NSE:HLVLTD
|
IN |
|
Meitu Inc
HKEX:1357
|
CN |
|
Schroder BSC Social Impact Trust PLC
LSE:SBSI
|
UK |
|
V
|
Vision International Holdings Ltd
HKEX:8107
|
HK |
|
S
|
Shijiazhuang Shangtai Technology Co Ltd
SZSE:001301
|
CN |
|
Huaxin Cement Co Ltd
HKEX:6655
|
CN |
|
Shenzhen Zqgame Co Ltd
SZSE:300052
|
CN |
|
Rail Vikas Nigam Ltd
NSE:RVNL
|
IN |
|
T
|
Telecom Argentina SA
BCBA:TECO2
|
AR |
|
Graco Inc
NYSE:GGG
|
US |
|
H
|
Huawen Media Group
SZSE:000793
|
CN |
Sequana Medical NV
Tax Provision
Sequana Medical NV
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sequana Medical NV
XBRU:SEQUA
|
Tax Provision
-€260.9k
|
CAGR 3-Years
21%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Nyxoah SA
XBRU:NYXH
|
Tax Provision
-€1m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
|
Ion Beam Applications SA
XBRU:IBAB
|
Tax Provision
-€6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
Sequana Medical NV
Glance View
Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 60 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.
See Also
What is Sequana Medical NV's Tax Provision?
Tax Provision
-260.9k
EUR
Based on the financial report for Jun 30, 2025, Sequana Medical NV's Tax Provision amounts to -260.9k EUR.
What is Sequana Medical NV's Tax Provision growth rate?
Tax Provision CAGR 5Y
-2%
Over the last year, the Tax Provision growth was 27%. The average annual Tax Provision growth rates for Sequana Medical NV have been 21% over the past three years , -2% over the past five years .
